glutathione synthetase ags cell line Anti-Glutathione antibody [EPR6562] (ab124811) NSUN2 lactylation drives cancer cell
NSUN2 lactylation drives cancer cell resistance to ferroptosis through enhancing GCLC dependent glutathione synthesis ScienceDirect Oncology Letters ABCC2 induces metabolic vulnerability and cellular ferroptosis via enhanced glutathione efflux in gastric cancer Wang 2024 Clinical and Translational Medicine Wiley Online Library Frontiers System Xc GSH GPX4 axis: An important antioxidant system for the ferroptosis in drug resistant solid tumor therapy
Pay in 4 interest-free payments of $6.79 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
![glutathione synthetase ags cell line Anti-Glutathione antibody [EPR6562] (ab124811) NSUN2 lactylation drives cancer cell](https://ars.els-cdn.com/content/image/1-s2.0-S2213231724004579-ga1.jpg)
![glutathione synthetase ags cell line Anti-Glutathione antibody [EPR6562] (ab124811) NSUN2 lactylation drives cancer cell](https://www.spandidos-publications.com/article_images/ol/23/3/ol-23-03-13224-g02.jpg)
![glutathione synthetase ags cell line Anti-Glutathione antibody [EPR6562] (ab124811) NSUN2 lactylation drives cancer cell](https://onlinelibrary.wiley.com/cms/asset/e358dd0f-ff50-404e-b9fc-5cfb53aefa62/ctm21754-fig-0007-m.jpg)
![glutathione synthetase ags cell line Anti-Glutathione antibody [EPR6562] (ab124811) NSUN2 lactylation drives cancer cell](https://www.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/910292/fphar-13-910292-HTML/image_m/fphar-13-910292-g001.jpg)